| Variable | 2nd Stage Success (N=53) | 2nd Stage Failure (N=22) | p-Value |
|---|---|---|---|
| N (%) | N (%) | ||
| Sex | .56 | ||
| Male | 28 (52.8) | 10 (45.5) | |
| Female | 25 (47.2) | 12 (54.6) | |
| Charlson Score | .19 | ||
| 0-1 | 28 (52.8) | 8 (36.4) | |
| ≥ 2 | 25 (47.2) | 14 (63.6) | |
| OR culture* | .56 | ||
| None/other | 29 (60.4) | 10 (52.6) | |
| MSSA/MRSA | 25 (47.2) | 9 (47.4) | |
| OR culture* | .49 | ||
| None/other | 41 (85.4) | 15 (79.0) | |
| MRSA | 7 (14.6) | 4 (21.1) | |
| Secondary surgery prior to explant | .11 | ||
| No | 30 (56.6) | 8 (36.4) | |
| Yes | 23 (43.4) | 14 (63.6) | |
| Other infected joints | .69 | ||
| No | 48 (90.6) | 19 (86.4) | |
| Yes | 5 (9.4) | 3 (13.6) | |